ABN AMRO Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.6M | Buy |
133,072
+5,679
| +4% | +$2.54M | 0.78% | 30 |
|
|
2025
Q1 | $61.7M | Buy |
127,393
+3,341
| +3% | +$1.62M | 0.85% | 31 |
|
|
2024
Q4 | $49.5M | Buy |
124,052
+7,383
| +6% | +$2.94M | 0.67% | 36 |
|
|
2024
Q3 | $53.8M | Buy |
116,669
+3,150
| +3% | +$1.45M | 0.74% | 34 |
|
|
2024
Q2 | $53.7M | Buy |
113,519
+2,178
| +2% | +$1.03M | 0.81% | 30 |
|
|
2024
Q1 | $46.6M | Buy |
111,341
+7,127
| +7% | +$2.98M | 0.7% | 32 |
|
|
2023
Q4 | $42.6M | Buy |
104,214
+7,473
| +8% | +$3.05M | 0.7% | 33 |
|
|
2023
Q3 | $33.6M | Buy |
96,741
+2,010
| +2% | +$699K | 0.61% | 34 |
|
|
2023
Q2 | $33.4M | Buy |
94,731
+1,737
| +2% | +$613K | 0.68% | 30 |
|
|
2023
Q1 | $29.3M | Buy |
+92,994
| New | +$29.3M | 0.65% | 30 |
|